Valuation: Stratec SE

Market Cap 28Cr 32Cr 26Cr 24Cr 45Cr 3.03TCr 45Cr 313.24Cr 121.32Cr 1.55TCr 118.59Cr 116.02Cr 4.97TCr P/E 2026 *
21x
P/E 2027 * 15.2x
Enterprise Value 37Cr 42Cr 35Cr 32Cr 60Cr 4.03TCr 60Cr 417.47Cr 161.69Cr 2.06TCr 158.05Cr 154.63Cr 6.62TCr EV / Sales 2026 *
1.41x
EV / Sales 2027 * 1.32x
Free-Float
38.87%
Yield 2026 *
2.79%
Yield 2027 * 3.38%
1 week-3.13%
Current month-7.39%
1 month+2.88%
3 months+35.04%
6 months+26.09%
Current year+4.27%
1 week 22.05
Extreme 22.05
24.7
1 month 22.05
Extreme 22.05
26.25
3 years 16.3
Extreme 16.3
49.4
5 years 16.3
Extreme 16.3
146.2
10 years 16.3
Extreme 16.3
147
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2011
Director of Finance/CFO 38 01/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 29/05/2019
Director/Board Member 73 21/07/2020
Chairman 68 20/05/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.72%-3.13%-18.17%-46.67% 32Cr
-0.50%+3.62%+45.40%+35.46% 25TCr
+0.32%+5.99%+21.45%-9.27% 16TCr
+1.42%+3.01%-8.15%+39.03% 14TCr
-1.70%+1.34%-55.27%-15.70% 6.37TCr
+0.65%-2.23%+13.17%+23.08% 4.97TCr
-0.03%+10.43%+40.04%+56.37% 4.87TCr
+3.19%+2.69%-14.50%-19.24% 4.79TCr
+0.75%+2.82%+48.62%+59.19% 4.26TCr
-1.42%+12.68%+194.47%+102.55% 4.08TCr
Average +0.16%+4.19%+26.71%+22.48% 9.38TCr
Weighted average by Cap. -0.25%+4.03%+25.98%+25.62%

Financials

2026 *2027 *
Net sales 26Cr 30Cr 25Cr 23Cr 42Cr 2.86TCr 43Cr 296.05Cr 114.66Cr 1.46TCr 112.08Cr 109.65Cr 4.7TCr 28Cr 32Cr 27Cr 24Cr 46Cr 3.09TCr 46Cr 320.24Cr 124.03Cr 1.58TCr 121.24Cr 118.62Cr 5.08TCr
Net income 1.32Cr 1.51Cr 1.25Cr 1.14Cr 2.13Cr 144.29Cr 2.14Cr 15Cr 5.78Cr 74Cr 5.65Cr 5.53Cr 236.91Cr 1.82Cr 2.08Cr 1.72Cr 1.57Cr 2.94Cr 199.13Cr 2.96Cr 21Cr 7.98Cr 101.73Cr 7.8Cr 7.63Cr 326.96Cr
Net Debt 9.22Cr 11Cr 8.71Cr 7.94Cr 15Cr 1.01TCr 15Cr 104.23Cr 40Cr 514.62Cr 39Cr 39Cr 1.65TCr 9.62Cr 11Cr 9.08Cr 8.28Cr 15Cr 1.05TCr 16Cr 108.72Cr 42Cr 536.76Cr 41Cr 40Cr 1.73TCr
Logo Stratec SE
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Employees
-
Date Price Change
28/26/28 €23.10 -0.43%
25/26/25 €23.20 +4.04%
24/26/24 €22.30 -0.45%
23/26/23 €22.40 -1.75%
22/26/22 €22.80 +0.44%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
22.80EUR
Average target price
25.60EUR
Spread / Average Target
+12.28%

Quarterly revenue - Rate of surprise